Ubiquitination in the antiviral immune response  by Davis, Meredith E. & Gack, Michaela U.
Review
Ubiquitination in the antiviral immune response
Meredith E. Davis, Michaela U. Gack n
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, United States
a r t i c l e i n f o
Article history:
Received 2 December 2014
Returned to author for revisions
12 February 2015
Accepted 17 February 2015












a b s t r a c t
Ubiquitination has long been known to regulate fundamental cellular processes through the induction of
proteasomal degradation of target proteins. More recently, ‘atypical’ non-degradative types of poly-
ubiquitin chains have been appreciated as important regulatory moieties by modulating the activity or
subcellular localization of key signaling proteins. Intriguingly, many of these non-degradative types of
ubiquitination regulate the innate sensing pathways initiated by pattern recognition receptors (PRRs),
ultimately coordinating an effective antiviral immune response. Here we discuss recent advances in
understanding the functional roles of degradative and atypical types of ubiquitination in innate
immunity to viral infections, with a speciﬁc focus on the signaling pathways triggered by RIG-I-like
receptors, Toll-like receptors, and the intracellular viral DNA sensor cGAS.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
Infection with viral pathogens triggers an immediate antiviral
response in the host cell, commonly termed ‘innate immune
response’. This response is characterized by rapid gene expression
of a variety of antiviral and inﬂammation-inducing molecules,
including type-I interferons (IFN-α/β), type-III IFNs (IFN-λ or IL-
28/29), proinﬂammatory cytokines and chemokines. Upon secre-
tion and subsequent binding to their respective receptors on the
surface of surrounding cells, IFNs lead to the upregulation of more
than one hundred different interferon-stimulated genes (ISGs)
(Ivashkiv and Donlin, 2014; Liu et al., 2011). ISGs encode for either
signaling molecules, including transcription factors, that amplify
the innate immune response, or for antiviral effector proteins to
block virus replication through multiple mechanisms, such as
cleavage of viral RNA or shutdown of host cell translation. Furth-
ermore, secreted proinﬂammatory cytokines and chemokines
produced during the innate immune response are critical for
priming and ﬁne-tuning the adaptive immune response (Sadler
and Williams, 2008; Sen and Sarkar, 2007).
One class of important molecules in the activation of the innate
antiviral response are pattern recognition receptors (PRRs), which
recognize viral proteins or speciﬁc features in the viral nucleic
acid, and then trigger immune signaling that results in IFN
production (Creagh, 2006; Takeuchi and Akira, 2010). At least
three major classes of PRRs recognizing viral nucleic acids have
been identiﬁed: (1) the cytosolic RIG-I-like receptors (RLRs)
sensing viral RNA species produced during both RNA and DNA
virus infections; (2) the membrane-bound Toll-like receptors
(TLRs) detecting viral RNA or DNA in endolysosomes immediately
after virus entry; and (3) a group of structurally-unrelated viral
DNA sensors, with cGAS (cyclic GMP-AMP synthase) representing
a key sensor of various DNA virus infections. Upon sensing of viral
nucleic acid, these sensors activate several kinases belonging to
the IKK (inhibitor of nuclear factor kappa-B [IκB] kinase) family,
namely the canonical IKKα and IKKβ together with their essential
regulatory subunit IKKγ/NEMO, as well as the non-canonical IKKε
and TANK-binding kinase-1 (TBK1). IKKα/β/γ and TBK1/IKKε then
activate the transcription factors NF-κB and IFN-regulatory factors
3 and 7 (IRF3/7), respectively. In addition, PRRs activate several
mitogen-activated protein kinases (MAPK), leading to the activa-
tion of AP-1 (activator protein-1). IRF-3/7, NF-κB and AP-1, upon
their translocation into the nucleus, transcriptionally induce IFNs
and other cytokines, ultimately establishing an antiviral program
in the infected host cell or uninfected surrounding cells (Loo and
Gale, 2011; Goubau and Deddouche, 2013).
Aberrant PRR activation and signaling can lead to chronic inﬂam-
mation and tissue damage, and potentially cause autoimmune
disorders. Indeed, recent ﬁndings indicated that some autoi-
mmune diseases, e.g. systemic lupus erythematosus and Aicardi-
Goutières Syndrome, are linked to single nucleotide polymorphisms
(SNPs) in PRRs that lead to their constitutive activation (reviewed in
(Kato and Fujita, 2014; Smith and Jefferies, 2014)). To prevent
premature or excessive activation of PRR-induced antiviral signaling,
an elegant system of regulation is in place. A key host mechanism for
modulating the stability and signaling activity of PRRs and their
downstream signaling molecules is reversible posttranslational mod-
iﬁcation (PTM), with phosphorylation and ubiquitination being the
most well studied PTMs. Here we focus on the role of ubiquitination
and the reversal of this process, deubiquitination, in the regulation of
three major innate sensing pathways of viral infections: the RLR, TLR
and cGAS-STING pathways.
Ubiquitin conjugation and deubiquitination of proteins
Ubiquitin is a small, 76 amino acid protein that is conserved
across eukaryotic organisms and can be covalently attached to
lysines or other residues in target proteins to modify their
stabilities or activities. Ubiquitin conjugation is completed through
step-wise catalysis using three distinct classes of enzymes, termed
E1, E2 and E3 (Pickart and Eddins, 2004; Chernorudskiy and
Gainullin, 2013). First, E1 activates the ubiquitin molecule in an
ATP-dependent manner by forming an intermediate thioester
bond between an active cysteine group in the E1 enzyme itself
and the ubiquitin C-terminus. The E1 ubiquitin-activating enzyme
next binds to the E2 enzyme, also called ubiquitin-conjugating
enzyme, which accepts the ubiquitin at a catalytic cysteine
residue. Finally, the E3 ubiquitin ligase, in complex with E2,
facilitates the transfer of the ubiquitin moiety to the substrate
protein by forming an isopeptide bond, usually between the
ɛ-amino group of a lysine in the substrate and the C-terminal
glycine residue of the ubiquitin molecule. Given that the E3 ligase
determines the substrate speciﬁcity and that there are many
different substrate proteins for ubiquitination in human cells, it
is not surprising that a large number (more than 700) of E3 ligases
exists. Furthermore, in humans, there are two E1 enzymes, which
usually do not have any speciﬁcity for the E2 or E3 enzyme, and
40 different E2 enzymes, whose primary function is to deter-
mine which types of polyubiquitin chains are catalyzed by the E3.
The E3 ubiquitin ligase superfamily can be classiﬁed into four
major families: Really Interesting New Gene (RING), homologous
to E6-associated protein C-terminus (HECT), UFD2 homology (U-
box), and RING-in-between-RING (RBR) E3 ligases (Berndsen and
Wolberger, 2014; Mattiroli and Sixma, 2014; Nagy and Dikic,
2010). Members of each E3 ligase family facilitate ubiquitin
conjugation to the target protein through different mechanisms.
RING E3 ligases, the most prevalent, never directly bind to the
ubiquitin moiety. Instead, they serve as mediators for direct
transfer of the ubiquitin molecule from the E2 enzyme to the
substrate. In contrast, in the case of HECT E3 ligases, an inter-
mediate bond between ubiquitin and a catalytic cysteine of the E3
ligase is formed before transfer of ubiquitin to the target protein.
U-box E3 ligases, also dubbed E4 ubiquitin ligases, primarily
elongate polyubiquitin chains that have already been begun by
another E3 ligase (Koegl et al., 1999). The recently identiﬁed family
of RBR E3 ligases (further reviewed in (Spratt et al., 2014)) are
structurally characterized by two domains which are bioinforma-
tically similar to RING domains, separated by an intervening
sequence called IBR (in-between-RING). RBR E3 ligases catalyze
ubiquitin conjugation through a hybrid mechanism in which the
ﬁrst RING domain acts as a canonical RING ligase, interacting with
the E2 enzyme, bringing it in proximity to the substrate. The
second RING domain, also called required for catalysis (Rcat), then
accepts the ubiquitin from the E2 enzyme before transferring it to
the substrate, similar to the action of a HECT ligase (Spratt et al.,
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2014; Wenzel et al., 2011). Two of the most highly studied RBR
ligases are Parkin, an E3 ligase involved in mitochondrial biology
and well-known for its implication in Parkinson's disease, and
LUBAC, the linear ubiquitination assembly complex, which plays
an important role in various antiviral and inﬂammatory signaling
pathways (as discussed in more detail below). The counterplayers
of the E2/E3 complex are deubiquitinating enzymes (DUBs),
cysteine proteases or metalloproteases that remove monoubiqui-
tin or polyubiquitin chains from substrate proteins. In humans,
there are 100 DUB enzymes which can be further categorized
into ﬁve main superfamilies dependent on their catalytic domains
and mechanisms of action: the ubiquitin-speciﬁc proteases (USP),
the ovarian tumor (OTU) superfamily, the ubiquitin C-terminal
hydrolases (UCH), the Machado-Josephin domain (MJD) super-
family, and the JAMM (JAB1/MPN/Mov34) metalloprotease family
(Reyes-Turcu et al., 2009).
During the past decade, it has become evident that E3 ligases
and DUBs play important roles in ﬁne-tuning innate immunity by
either modulating the stability of key molecules in the immune
system, or by regulating cytokine production through synthesis (or
removal) of unconventional types of polyubiquitin that are neces-
sary for innate signal transduction.
Functional roles of different linkage types of
polyubiquitination
Conjugation of ubiquitin to substrates generally occurs at lysine
residues, but may also occur at cysteine, serine, threonine, and
tyrosine residues (McDowell and Philpott, 2013). Residues can be
modiﬁed with a single ubiquitin moiety (monoubiquitination),
two ubiquitin proteins (diubiquitination), or chains of ubiquitin
(polyubiquitination). Polyubiquitin chains are usually formed
through covalent binding of the C-terminal glycine of one ubiqui-
tin molecule to an internal lysine residue of another ubiquitin
molecule. As ubiquitin harbors seven internal lysine residues (K6,
K11, K27, K29, K33, K48, and K63), seven different types of
polyubiquitin chains can arise (Fig. 1) (McDowell and Philpott,
2013; Ikeda et al., 2010). Among them, K48-linked ubiquitination,
the classical ubiquitination involved in proteasomal degradation,
and K63-linked polyubiquitination represent the most well stu-
died polyubiquitin types. Additionally, the C-terminus of one
ubiquitin molecule can also bind to the N-terminal methionine
of another ubiquitin molecule, giving rise to ‘linear ubiquitination’
(also called ‘head-to-tail’ or Met1 ubiquitination). Polyubiquitin
chains are usually covalently linked to the substrate; however,
over the past several years, it has become clear that polyubiquitin
chains can also be bound non-covalently by substrate proteins.
The cellular fate of ubiquitinated proteins varies greatly based
on the linkage type of ubiquitin chains formed on the modiﬁed
residue (Fig. 1) (Ikeda et al., 2010; Kulathu and Komander, 2012).
Classical K48-linked polyubiquitin chains are generally recognized
by the proteasome, leading to degradation of the substrate, a
mechanism utilized for normal protein turnover in the cell. In
contrast, K63-linked ubiquitination does not usually trigger pro-
teasomal degradation, but instead plays an important role in signal
transduction pathways. Mechanistically, K63-linked ubiquitination
of proteins has been shown to activate signaling pathways by
either stabilizing substrates, or by acting as a scaffold for the
formation of a signaling multi-complex. Speciﬁcally, K63-linked
ubiquitination can promote the multimerization of signaling pro-
teins, thereby inducing their active states, allowing for the recruit-
ment of additional interaction partners and ultimately signal
transduction. Furthermore, K63-linked ubiquitination can lead to
the formation of an active signaling complex through recruitment
of binding partners that harbor speciﬁc ubiquitin-binding domains
(UBDs) that recognize K63-polyubiquitin-modiﬁed proteins.
As with K63-linked ubiquitination, linear ubiquitin chains
positively regulate signal transduction events rather than leading
to protein degradation (Walczak et al., 2012). Linear ubiquitination
is catalyzed by LUBAC, an E3 ligase complex consisting of heme-
oxidized iron-responsive element binding protein 2 ubiquitin
ligase-1 (HOIL-1) and HOIL-1-interacting protein (HOIP), often
complexed with SHANK-associated RH domain-interacting protein
(SHARPIN) (Kirisako et al., 2006; Tokunaga et al., 2011; Gerlach
et al., 2011; Ikeda et al., 2011). The functions of the remaining ﬁve
polyubiquitin linkages are much more enigmatic. Treatment with
proteasomal inhibitors leads to cellular enrichment of not only
K48-linked polyubiquitin, but also K11-, K29-, and K33-linked
polyubiquitin, suggesting that these ubiquitin linkage types may
also play roles in protein degradation (Wagner et al., 2011; Kim
et al., 2011; Kravtsova-Ivantsiv and Ciechanover, 2012). In contrast,
K6-linked ubiquitin chains seem not to be involved in protein
degradation, but may be connected to DNA damage (Kulathu and
Komander, 2012); however, the exact outcomes of K6-linked
ubiquitination of substrates remain largely unclear. K11-linked
ubiquitination is thought to speciﬁcally regulate the proteasomal
degradation of proteins that are involved in cell cycle regulation;
consistent with this, the levels of K11-linked ubiquitin chains vary
at different time points during the cell cycle (Matsumoto et al.,
2010). This leads to speculation that perhaps K11-linked ubiquiti-
nation speciﬁcally targets proteins involved in cell cycle control for
degradation, while K48-linked ubiquitination acts as a more
general cellular degradation signal. K11-linked polyubiquitination
has also been shown to have an activating role in tumor necrosis
Fig. 1. Functional roles of the different linkage types of polyubiquitination. The
8 different linkage types of polyubiquitination are illustrated. Known fates of
modiﬁed substrates as well as key pathways regulated by speciﬁc polyubiquitins
are shown. The speciﬁc details of how different ubiquitin polymers regulate
substrate proteins are described in the text.
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factor (TNF) signaling (Dynek et al., 2010). Finally, K11-linked
ubiquitination of MHC (major histocompatibility complex) class I
mediated by the K5 protein of Kaposi's sarcoma herpes virus
(KSHV) leads to receptor internalization and immune evasion
(Goto et al., 2010; Boname et al., 2010).
K27-linked ubiquitination has also been implicated in protein
degradation; however, its primary role seems to be in the mod-
iﬁcation of mitochondrial proteins, triggering the induction of
mitophagy. This mechanism is particularly well-characterized for
Parkin, which leads to the K11-linked ubiquitination of multiple
mitochondrial proteins, inducing their degradation (Glauser et al.,
2010, 2011). K27-linked ubiquitination has also been shown to
regulate the differentiation of regulatory T cells (Peng et al., 2011).
The least is known about K29- and K33-linked polyubiquitination.
Interestingly, members of the AMP-activated protein kinase
(AMPK) family can be modiﬁed with both K29- and K33-linked
ubiquitin chains. These modiﬁcations did not affect the protein
stability of AMPKs, but inhibited their activities through an
unidentiﬁed mechanism (Al-Hakim et al., 2008). One study has
also linked K33-linked ubiquitination to non-proteolytic regula-
tion of T-cell receptor signal transduction (Huang et al., 2010).
Much more work is needed to delve into the fates of these atypical
ubiquitin linkages to determine the linkage-speciﬁc fates of
protein substrates.
In addition to the described homogenously-linked polyubiqui-
tin chains, in the past few years mixed or branched chains
of polyubiquitin have been identiﬁed (Nakasone et al., 2013;
Kirkpatrick et al., 2006). However, to date it remains largely
unclear how these mixed ubiquitin linkages are made and what
roles they play.
Recently, a role for unanchored or ‘free’ ubiquitin chains has
been described. These chains are generated by E2/E3 ligases, but
are not covalently conjugated to a substrate protein, and instead
are bound non-covalently. To date, three linkage types of unan-
chored polyubiquitin have been identiﬁed, K63-linked, K48-linked
and linear ubiquitin chains, all of which play important roles in
innate immune signaling. Unanchored K63-linked and linear
ubiquitin chains have been described for their roles in promoting
NEMO and/or RIG-I signaling (as described in detail below).
Unanchored K48 ubiquitin chains were recently shown to play a
positive regulatory role in type-I IFN receptor (IFNAR) signal
transduction. Speciﬁcally, upon IFNAR activation, IKKε binds to
unanchored K48-linked ubiquitin chains, which activates IKKε to
phosphorylate signal transducer and activator of transcription 1
(STAT1), ultimately triggering expression of antiviral ISGs
(Rajsbaum et al., 2014a).
The role of ubiquitin in RLR signal transduction
The RLRs are a family of DExD/H-box helicases which recognize
viral RNA species in the cytosol of infected cells. The two best-
studied RLR members are retinoic acid-inducible gene-I (RIG-I)
and melanoma differentiation-associated protein 5 (MDA5), criti-
cal for the detection of viral 50triphosphorylated RNA or long
dsRNA, respectively (reviewed in detail in (Goubau and
Deddouche, 2013; Schlee, 2013)). In addition, it has been recently
shown that RIG-I can also detect viral RNA containing a dipho-
sphate moiety (Goubau et al., 2014). Functional studies in RIG-I
and MDA5 knockout (KO) cells showed that RIG-I senses inﬂuenza
viruses, arenaviruses and vesicular stomatitis virus (VSV), while
MDA5 detects picornaviruses. Furthermore, many RNA viruses
including Flaviviruses, reoviruses and paramyxoviruses are sensed
both by RIG-I and MDA5, often in a temporally-distinct manner
(Loo and Gale, 2011; Kato et al., 2006). RIG-I has also been
implicated in the detection of various DNA viruses (e.g. Epstein-
Barr virus and adenoviruses) by sensing 50-triphosphorylated
small RNAs produced during replication. The third RLR member,
LGP2 (laboratory of genetics and physiology 2), is not believed to
have sensing capacity but instead, has been shown to have a
regulatory role (reviewed in (Rodriguez et al., 2014)). All three RLR
proteins share a helicase and C-terminal domain (CTD), both
of which confer RNA binding ability (Yoneyama et al., 2004;
Andrejeva et al., 2004). Additionally, RIG-I and MDA5, but not
LGP2, harbor two N-terminal caspase activation and recruitment
domains (CARDs), which are critical for downstream signaling and
IFN induction. After binding to their RNA ligands, RIG-I and MDA5
oligomerize and interact with MAVS (also known as Cardif, IPS-1
or VISA) on mitochondria via CARD–CARD interactions (Kawai
Fig. 2. Regulation of RLRs by ubiquitination. RIG-I and MDA5, members of the RIG-
I-like receptor (RLR) family, recognize cytoplasmic viral RNA species and subse-
quently signal through the adaptor protein MAVS (also called Cardif, IPS-1, or VISA)
on mitochondria. Through various steps (not illustrated), MAVS activates down-
stream signaling, leading to gene expression of type-I IFNs (IFN-α/β). The stability
and signaling activities of RIG-I, MDA5 and MAVS are tightly regulated by K48- and
K63-linked polyubiquitination, respectively. RIG-I is activated by K63-linked
ubiquitination mediated by TRIM25, an IFN-inducible E3 ubiquitin ligase belonging
to the large family of TRIM proteins. TRIM25 ubiquitinates several lysines in the
N-terminal caspase activation and recruitment domains (CARDs) of RIG-I (not
illustrated). TRIM25-mediated ubiquitination speciﬁcally at K172 in RIG-I is critical
for RIG-I signaling. In addition, TRIM4 and MEX3C were shown to induce K63-
linked ubiquitination of the RIG-I CARDs. Furthermore, RIPLET induces K63-linked
ubiquitination of K788 (and also other residues) in the C-terminal domain (not
illustrated). Both RIG-I and MDA5 have been reported to non-covalently bind
unanchored K63-linked ubiquitin chains in vitro; however, the role of MDA5
activation by K63-linked ubiquitin chains remains unclear. TRIM25 itself undergoes
K48-linked ubiquitination catalyzed by LUBAC, leading to TRIM25 degradation.
Inversely, USP15 antagonizes the LUBAC-induced K48-linked ubiquitination of
TRIM25, thereby stabilizing TRIM25 during viral infection, which leads to a
sustained IFN response. MAVS is ubiquitinated with K63-linked polyubiquitin
chains; however, the E3 ligase for MAVS K63-ubiquitination is unknown. Multiple
different E3 ubiquitin ligases have been reported to induce the K48-linked
ubiquitination of RLRs and MAVS, triggering their degradation by the proteasome:
RNF125 for RIG-I; TRIM13 and RNF125 for MDA5; and AIP4/Itch, Smurf1/2, RNF5
and RNF125 for MAVS. The K48-linked ubiquitination of RIG-I can be actively
removed by USP4. Furthermore, TRIM44, an atypical TRIM protein that lacks the
RING E3 ligase domain, inhibits the K48-linked ubiquitination of MAVS through an
unidentiﬁed mechanism.
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et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005).
Activated MAVS then initiates a signaling cascade, which intersects
with the signaling pathway induced by several other innate
immune receptors (e.g. TLR or cGAS), resulting in the activat-
ion of IRF3/7, AP-1 and NF-κB, which function to trigger transcrip-
tional activation of IFNs and proinﬂammatory cytokines (Loo and
Gale, 2011; Belgnaoui et al., 2011).
Activation of RIG-I–MAVS signaling by K63-linked polyubiquitin
Over the past several years, it has become evident that K63-
linked polyubiquitination plays a crucial role in promoting RLR
signaling (Fig. 2). The regulation of RIG-I by K63-linked ubiquitin
chains has been particularly well-characterized. Mass spectro-
metry and biochemical analyses showed that the N-terminal
CARDs of RIG-I undergo K63-linked ubiquitination by TRIM25
(also called estrogen-responsive ﬁnger protein [EFP]), an IFN-
inducible E3 ligase belonging to the tripartite motif (TRIM) protein
family (Gack et al., 2007). This study showed that upon viral
infection, TRIM25 binds using its C-terminal SPRY domain to the
ﬁrst CARD of RIG-I; the RING E3 ligase activity of TRIM25 then
conjugates covalent K63-polyubiquitin chains to the residue K172
in the second CARD of RIG-I (as well as to ﬁve other lysine
residues: K99, K169, K181, K190 and K193). Before TRIM25–RIG-I
binding and RIG-I ubiquitination, speciﬁc serine and threonine
residues in the RIG-I CARDs must be dephosphorylated by PP1α/γ
(Gack et al., 2010; Nistal-Villan et al., 2010; Wies et al., 2013;
Maharaj et al., 2012). The K63-linked ubiquitin chains on RIG-I
promote RIG-I's interaction with MAVS, evidenced by mutation of
K172 in RIG-I as well as trim25 gene targeting, both of which
profoundly reduced the RIG-I CARD ubiquitination and binding of
RIG-I to MAVS (Gack et al., 2007, 2008; Rajsbaum et al., 2012).
Functional studies in mouse embryonic ﬁbroblast cells (MEFs)
deﬁcient in the trim25 gene demonstrated that TRIM25 is an
important activator of RIG-I and critical for an effective IFN-
mediated immune response to various RNA virus infections.
Notably, no covalent K63-linked ubiquitination of the MDA5
CARDs, with or without ectopic expression of TRIM25, was
detected in human cells (Gack et al., 2007). This study showed
for the ﬁrst time that a member of the TRIM family, comprising
70 proteins in humans, promotes PRR signaling through con-
jugation of unconventional polyubiquitin, thereby inducing type-I
IFNs. Intriguingly, in the past few years, it has been shown that
several other TRIM members – all characterized by the RBCC motif
comprised of a RING, B-box and Coiled-coil domain (CCD) –
regulate PRR signaling pathways by catalyzing K63-linked ubiqui-
tin chains or other non-degradative types of polyubiquitin. More-
over, some TRIM proteins also conjugate degradative K48-linked
ubiquitination to key signaling molecules in innate immunity,
thereby dampening antiviral and proinﬂammatory responses.
Thus, TRIM proteins represent an important class of immunor-
egulatory molecules in innate signaling pathways. In addition,
several TRIM members act as antiviral restriction factors (e.g.
TRIM5α and TRIM79α) by directly interacting with viral proteins
to block virus replication (Gack, 2011; Rajsbaum et al., 2014b;
McNab et al., 2011).
Besides TRIM25, an additional E3 ligase has been reported to
regulate RIG-I through K-63-linked ubiquitination. Riplet (also
called RNF135 or REUL) has been shown to ubiquitinate RIG-I,
facilitating its activation (Oshiumi et al., 2009; Gao et al., 2009).
In vivo studies conﬁrmed the importance of this E3 ligase in
regulating RIG-I signaling: Riplet-deﬁcient mice produced less IFN
and were more susceptible to VSV infection than wild-type (WT)
mice (Oshiumi et al., 2010). While these studies conﬁrmed an
important role of Riplet in RIG-I ubiquitination and activation,
some of the mechanistic details – speciﬁcally which domain and
residues in RIG-I are targets of ubiquitination by Riplet – still
remain somewhat unclear. While one study suggested that Riplet
ubiquitinated residues in the N-terminal CARDs (Gao et al., 2009),
others demonstrated that Riplet ubiquitinated several lysine
residues in the CTD of RIG-I, of which K788 seemed to be the
functionally important residue for regulating RIG-I signaling
(Oshiumi et al., 2009, 2013).
The importance of TRIM25- and Riplet-mediated ubiquitination
in RIG-I activation was strengthened by the ﬁnding that the non-
structural protein 1 (NS1) of inﬂuenza A virus (IAV) antagonizes
both E3 ligases (Rajsbaum et al., 2012; Gack et al., 2009). Initial
studies demonstrated that NS1 interacts with human TRIM25,
preventing the K63-linked ubiquitination of the RIG-I CARDs (Gack
et al., 2009). This was shown to be due to NS1 interacting with the
CCD of TRIM25, preventing TRIM25 dimerization, which appears
to be critical for TRIM25's enzymatic activity to induce ubiquitina-
tion of RIG-I. A recombinant IAV containing an NS1 protein that
cannot interact with TRIM25 (E96A/E97A NS1 mutant) did not
have an inhibitory effect on the ubiquitin-dependent signaling
activity of RIG-I (Gack et al., 2009). The lack of conservation of
K172 between human and mouse RIG-I led to additional studies
looking at the antagonism of RIG-I by the inﬂuenza NS1 protein in
cells from different host species. This study showed that while NS1
from human, avian, porcine, and murine IAV strains were all able
to interact with human TRIM25, none of the tested NS1 proteins
interacted with mouse TRIM25. Instead, NS1 efﬁciently bound to
mouse Riplet; however, the ability of NS1 proteins to interact with
Riplet was not limited to the murine ortholog. In fact, NS1 proteins
from human IAV strains were also able to interact with human
Riplet, blocking both TRIM25 and Riplet in human cells, which led
to profound inhibition of RIG-I-mediated antiviral signaling
(Rajsbaum et al., 2012). Mechanistically, there is evidence that
Riplet induces K63-linked ubiquitination of the CTD of RIG-I ﬁrst,
which likely stabilizes an open conformation of the RIG-I mole-
cule, in which the CARDs are now accessible for TRIM25 binding
and TRIM25-mediated ubiquitination, ultimately promoting RIG-I–
MAVS interaction (Oshiumi et al., 2013; Gack, 2014). Further
studies are needed to fully understand the species-speciﬁc roles
of TRIM25 and Riplet in RIG-I activation, and how these two E3
ligases act in concert to stimulate RIG-I downstream signaling for a
rapid and effective antiviral response.
Recently, there have been reports suggesting a role for unan-
chored K63-linked polyubiquitin chains in the signal activation of
RIG-I. Using a cell free system, Zeng et al. showed that in vitro-
generated K63-, but not K48- or linear, polyubiquitin chains were
able to bind to RIG-I and facilitate its ability to activate IRF3 (Zeng
et al., 2010). Subsequent studies showed that the MDA5 CARDs are
also able to interact with unanchored K63-linked ubiquitin chains
in vitro (Jiang et al., 2012), enabling MDA5 to activate IRF3.
However, these studies on MDA5 K63-ubiquitin binding were
challenged by Wu et al. who did not observe MDA5 activation by
K63-polyubiquitin, leaving the role of K63-polyubiquitin in MDA5
activation ambiguous (Wu et al., 2013a).
In regards to RIG-I, the discrepancy between its covalent K63-
linked ubiquitination and ability to bind unanchored K63-ubiquitin
resulted in the important question of which type of K63-linked
polyubiquitin – covalent or non-covalent – is important for RIG-I
activation. The recently solved crystal structure of the RIG-I CARDs
demonstrated that three K63-ubiquitin chains are bound along the
outer rim of the RIG-I 2CARD tetramer, stabilizing the CARDs in a ‘lock-
washer’ conformation (Peisley et al., 2014). Importantly, this study
provided several lines of evidence that covalent K63-ubiquitination is
important for RIG-I CARD-mediated signaling. First, they showed that
residue K172 in RIG-I, previously identiﬁed to be covalently attached to
K63-ubiquitin (Gack et al., 2007), is not involved in an interactionwith
unanchored K63-ubiquitin chains. In fact, the structural analysis
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showed that K172 is within the covalent linkage distance (o20 Å)
from the C-terminus of ubiquitin, strongly indicating that this residue
is covalently modiﬁed. Furthermore, this study showed that
covalently-attached K63-ubiquitin chains stabilized the signaling-
active RIG-I tetramer more efﬁciently than non-covalent K63-diubi-
quitin (Peisley et al., 2014).
A recent study has implicated a third ubiquitin E3 ligase, TRIM4, in
regulating RIG-I signal transduction. Overexpression of TRIM4 led to
increased IFN induction following infection with Sendai virus (SeV), a
paramyxovirus known to be detected by RIG-I (Yan et al., 2014). More
detailed analysis indicated that TRIM4 interacted with RIG-I and led to
the K63-linked ubiquitination of K154, K164, and K172 in the CARDs.
However, the physiological role and contribution of K63-linked
ubiquitination of RIG-I by TRIM4 to innate antiviral immunity has
yet to be determined. Another regulatory mechanism of RIG-I activity
through K63-linked ubiquitination was recently discovered involving
antiviral stress granules (avSG) (Kuniyoshi et al., 2014). The E3 ligase
MEX3C was shown to bind to viral RNA, resulting in its association
with RIG-I inside avSGs. This study indicated that K48, K99 and K169
of RIG-I were ubiquitinated by MEX3C, and that this ubiquitination
increased type-I IFN induction. While this study strengthened the
hypothesis that RIG-I's subcellular localization may be important for
viral RNA detection, the exact role of avSGs in innate immune
signaling remains unclear. As K63-linked ubiquitination of RIG-I is
crucial for its signaling activity in response to virus infection, it is not
surprising that several DUBs have been identiﬁed that counteract this
modiﬁcation. At least three different DUBs have been implicated in the
inhibition of RIG-I signaling through the removal of covalent K63-
linked ubiquitin chains (Fig. 2). Cylindromatosis (CYLD) was the ﬁrst
DUB identiﬁed that led to RIG-I deubiquitination. In uninfected cells,
CYLD was shown to keep RIG-I deubiquitinated, preventing any basal
activation levels (Friedman et al., 2008). This study further showed
that, upon viral infection, CYLD protein abundance was downregu-
lated, presumably allowing the full ubiquitination and activation of
RIG-I. Notably, CYLD's activity was not speciﬁc for RIG-I as TBK1 and
IKKε were also targets of CYLD-mediated deubiquitination. Similarly,
USP21 has been reported to negatively regulate RIG-I by removing
K63-linked ubiquitination (Fan et al., 2014). USP21 was shown to
interact with RIG-I both in uninfected cells and during VSV and SeV
infection. This interaction led to RIG-I deubiquitination and a decrease
in type-I IFN induction. More recently, USP3 has been shown to
deubiquitinate RIG-I, leading to a decrease in IFN-β induction (Cui et
al., 2014). Upon virus infection, USP3 interacted with RIG-I, likely
acting as a negative feedback regulator. Interestingly, this study also
showed a negative regulatory effect of USP3 on MDA5 activity;
however, the precise mechanism by which USP3 affects MDA5's
signaling activity remains unclear, given the elusive role of K63-
polyubiquitin in MDA5 activation. Additionally, several studies have
shown that viruses encode DUBs to target RIG-I and to evade detection
by the innate immune system (reviewed in (Chiang et al., 2014)). This
large number of cellular and viral DUBs speciﬁcally targeting the K63-
linked ubiquitination of RIG-I further conﬁrms the importance of this
type of ubiquitination in RIG-I activation.
RIG-I's immediate downstream interaction partner, the adaptor
protein MAVS, has also been shown to be regulated by K63-linked
ubiquitination (Paz et al., 2009). K63-linked ubiquitination of K500
in MAVS was induced following SeV infection and led to the
enhanced recruitment of IKKε, ultimately promoting IRF3 acti-
vation and type-I IFN gene expression. The ligase(s) responsible for
the K63-linked ubiquitination of MAVS at K500, however, have not
yet been identiﬁed.
Negative regulation of RLR signaling by K48-linked ubiquitination
In addition to positive regulation through K63-linked ubiquitina-
tion, RIG-I has been shown to be degraded in a proteasome-dependent
manner based on conjugation of K48-linked polyubiquitin. It was ﬁrst
reported that the RING E3 ligase RNF125 binds to and ubiquitinates
RIG-I with K48-linked polyubiquitin chains (Fig. 2). This ubiquitin mark
led to RIG-I degradation and decreased SeV-induced IFN induction,
indicating a negative-feedback loop by regulating RIG-I protein levels
(Arimoto et al., 2007). The same study showed that RNF125 does not
act speciﬁcally on RIG-I, but also interacted with and ubiquitinated
MDA5 and MAVS as well – although to a lesser extent (Arimoto et al.,
2007). This identiﬁed RNF125 as a relatively non-speciﬁc negative
regulator of the RLR pathway by targeting both RIG-I and MDA5 as
well as MAVS for degradation. The K48-linked ubiquitination of RIG-I is
counteracted by USP4, stabilizing the protein levels of RIG-I and
prolonging IFN induction (Wang et al., 2013). Interestingly, USP4
protein levels decrease following virus infection, indicating that it is
involved in steady-state regulation of RIG-I.
MDA5 was reported to be negatively regulated by another E3
ubiquitin ligase, TRIM13 (Narayan et al., 2014). This study showed
that overexpression of TRIM13 inhibited MDA5-mediated signal-
ing. Furthermore, infection with encephalomyocarditis virus
(EMCV) induced signiﬁcantly higher type-I IFN levels in
trim13 / mice than in WT mice (Narayan et al., 2014). In sup-
port of this, trim13 / mice had an increased resistance to EMCV
infection than their WT littermates. Of note, this study did not look
speciﬁcally at MDA5 ubiquitination by TRIM13; however, as
TRIM13 has a functional RING E3 ligase domain, it is likely that
the mechanism involves degradative K48-linked ubiquitination.
More detailed studies are needed to deﬁne the mechanistic action
of TRIM13 in MDA5 signal transduction.
Both HECT and RING E3 ligases have been shown to function as
negative regulators of MAVS signaling by inducing its K48-linked
ubiquitination. Besides ubiquitination by RNF125, MAVS under-
goes K48-linked ubiquitination at residues K371 and K420 by the
HECT E3 ligase AIP4 (Atrophin 1 Interacting Protein 4; also called
ITCH) (You et al., 2009). Notably, AIP4/ITCH is not present on the
mitochondria during steady state, but is speciﬁcally recruited
there upon viral infection by the RNA-binding protein PCBP2
(poly(rC) binding protein 2), ultimately triggering the proteasomal
degradation of MAVS. Experiments in itch / MEFs showed that
the absence of AIP4 led to sustained production of several
cytokines (e.g. type-I IFNs, TNF, and IL6) in response to poly(I:C)
transfection or SeV infection (You et al., 2009). Furthermore, the
SMAD ubiquitin regulatory factors (Smurf) 1 and 2 have been
shown to induce the K48-linked ubiquitination and degradation of
MAVS (Wang et al., 2012b; Pan et al., 2014). In the case of Smurf1,
Ndﬁp1, known for its role in the activation of the Nedd4 family of
HECT E3 ligases, was critical for MAVS binding and degradation.
Finally, RNF5 has been reported to interact with MAVS upon viral
infection, regulating MAVS stability through targeting K362 and
K461 in MAVS for K48-linked ubiquitination (Zhong et al., 2010).
Interestingly, TRIM44 has been shown to counteract the K48-
polyubiquitin-induced degradation of MAVS (Yang et al., 2013a).
TRIM44 overexpression led to increased MAVS stability and
enhanced IFN induction by suppressing the PCBP2/AIP4-induced
ubiquitination of MAVS. Of note, TRIM44 is an atypical TRIM
protein because it lacks the RING ﬁnger domain; instead TRIM44
possesses a ZF-UBP domain, which is typically found in members
of the USP family. Further studies will be needed to deﬁne the
precise mechanism by which TRIM44 stabilizes MAVS, and speci-
ﬁcally whether the putative DUB activity of TRIM44 plays a role in
MAVS regulation.
Recent studies have identiﬁed LUBAC as a negative feedback
regulator of the TRIM25–RIG-I signaling complex. LUBAC, com-
posed of the E3 ligases HOIL-1L and HOIP, has been shown to
negatively regulate RIG-I signaling utilizing two distinct mechan-
isms (Inn et al., 2011). First, LUBAC induces ubiquitination of the C-
terminal SPRY domain of TRIM25, leading to TRIM25 proteasomal
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degradation. While LUBAC was able to catalyze both linear
ubiquitin chains and K48-linked ubiquitin chains on TRIM25
in vitro, cell culture studies indicated that LUBAC regulates TRIM25
stability primarily through classical K48-linked ubiquitination.
TRIM25 ubiquitination was depended on the RBR domains of both
HOIL-1L and HOIP. Additionally, a second mechanism for LUBAC
inhibition of TRIM25 and RIG-I was suggested, which was
depended on the NZF (Npl4 zinc ﬁnger) domain of HOIL-1L.
Speciﬁcally, the NZF of HOIL-1L competes with TRIM25 for RIG-I
binding, ultimately preventing TRIM25-mediated ubiquitination
and activation of RIG-I (Inn et al., 2011). USP15, identiﬁed as an
interaction partner of TRIM25 by mass spectrometry, was recently
shown to counteract the inhibitory effect of LUBAC (Pauli et al.,
2014). Mechanistically, USP15 was found to bind to TRIM25
speciﬁcally during the later stages of viral infection, removing
the LUBAC-induced K48-linked polyubiquitination of TRIM25 at its
SPRY domain. This study indicated that USP15 speciﬁcally stabi-
lizes the TRIM25 protein levels at later time points during
infection, which led to sustained type-I IFN gene expression,
facilitating virus clearance.
Regulation of TLR signaling through polyubiquitination
The TLR family consists of multiple members of membrane-
bound receptors (TLR 1-10 in humans) that have evolved to
recognize a wide array of PAMPs from viruses, bacteria, parasites
and fungi. The TLRs responsible for sensing viral infections include
TLR2 and TLR4 which sense viral proteins, as well as TLR3, TLR7/8,
and TLR9 which recognize virus-derived dsRNA, ssRNA, and
unmethylated CpG DNA, respectively (Medzhitov, 2001; Gay et
al., 2014). TLR proteins share common structural components
including an ectodomain comprising leucine-rich repeats that
are responsible for surveillance of ligands, a transmembrane
domain, and a cytoplasmic Toll-interleukin-1 receptor (IL-1R)
homology (TIR) domain which coordinates downstream signaling.
Upon binding to their ligands, the TLRs initiate signaling cascades
by binding to one of two key adaptor proteins: MyD88 or TRIF
(Akira and Takeda, 2004; O'Neill and Bowie, 2007). Classically,
MyD88 recruits the IL-1R-associated serine/threonine kinases
(IRAKs) 1, 2, and 4. MyD88 and IRAKs then signal to tumor
necrosis factor receptor-associated factor 6 (TRAF6), inducing the
recruitment and activation of IKKα/β/γ and TGFβ-activated kinase
1 (TAK1), which promote NF-κB activation and proinﬂammatory
cytokine production. On the other hand, TRIF signals downstream
through TRAF3, inducing IRF3/7-mediated IFN-α/β induction via
TBK1/IKKε. All TLRs, aside from TLR3, activate the MyD88-
dependent pathway, while TLR3 signals through TRIF. TLR4 can
activate both MyD88- and TRIF-dependent signaling pathways.
Over the past few years, ubiquitination has been shown to play an
important role in modulating the activities of key molecules in the
TLR pathway, both receptor-proximal molecules as well as down-
stream signaling proteins.
K48-linked ubiquitination of TLRs and their essential adaptor proteins
Multiple E3 ligases have been reported to regulate TLR signaling
through K48-linked ubiquitination of the TLRs themselves or their
adaptors MyD88 and TRIF (Fig. 3). This ubiquitin mark delicately
regulates the protein abundance of these signaling proteins, repre-
senting a negative feedback loop to prevent extended activation of
the innate immune system. Triad3A has been identiﬁed as an E3
ligase that binds to and ubiquitinates several members of the TLR
family (Chuang and Ulevitch, 2004). Triad3Awas originally identiﬁed
as an interactor of TLR9 through yeast two-hybrid screening. More
detailed studies showed that Triad3A interacts not only with TLR9
but also with TLR 3, 4, and 5, but not TLR2. Overexpression of Triad3A
led to K48-linked polyubiquitination and degradation of TLR 4 and 9,
and to a lesser extent TLR 3 and 5. In line with this, overexpression of
Triad3A inhibited the signaling abilities of these TLRs. Subsequent
studies indicated that Triad3A may also play a role downstream of
TLRs (and also RLRs) by targeting two key signaling molecules for
degradation: receptor-interacting protein 1 (RIP1) and TNF receptor-
associated factor 3 (TRAF3) (Nakhaei et al., 2009; Fearns et al., 2006).
The protein levels of MyD88 are also tightly regulated via K48-
linked ubiquitination, which was ﬁrst discovered when cells were
stimulated with the anti-inﬂammatory cytokine transforming
growth factor-β (TGF-β) (Naiki et al., 2005). Subsequent studies
showed that the E3 ubiquitin ligases Smurf1 and 2 bound to
MyD88, an interaction which was dependent on SMAD6 (Lee et al.,
2011). The interaction of MyD88 with Smurf1/2 led to the
ubiquitination and degradation of MyD88, limiting the inﬂamma-
tory response induced by TLR signaling. neuregulin receptor
degradation protein 1 (Nrdp1) is another E3 ligase which leads
to MyD88 degradation, but it has a more complex role in TLR
signaling. Nrdp1 acts at two steps of the TLR signaling pathway to
shift the response from NF-κB- to IRF3-driven gene expression
(Wang et al., 2009). Mechanistically, Nrdp1 attaches K48-linked
polyubiquitin to MyD88, leading to its degradation, and on the
other hand, conjugates K63-linked polyubiquitin to TBK1, activat-
ing the IRF3-dependent response. Thus, the dual activity of Nrdp1
coordinates distinct signaling of one arm of the TLR response,
while dampening the other arm of this pathway.
The adaptor protein TRIF, which speciﬁcally mediates signaling
by TLR3, has also been shown to be a target of K48-linked
ubiquitination. TLR3 senses viral dsRNA and subsequently associ-
ates through its TIR domain with TRIF, triggering the activation of
TRAF3 and TBK1, ultimately leading to type-I IFN induction. To
keep the TLR3–TRIF mediated signal transduction pathway in
Fig. 3. Regulation of TLRs by ubiquitination. Toll-like receptors (TLRs), found on the
cell surface or on endosomal membranes, survey the extracellular milieu for viral
nucleic acid or proteins. After binding to their respective viral ligands, TLRs signal
through one of two critical adaptor proteins, MyD88/IRAK or TRIF. Signaling by
IRAK1 is perpetuated through modiﬁcation with K63-linked ubiquitination by
Pellinos or TRAF6. The activation of TLRs and their adaptor proteins is regulated by
degradative K48-linked ubiquitination mediated by the E3 ligases indicated. The
speciﬁc details of how K48-polyubiquitin regulates TLR signaling are described in
the text.
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check, TRIF is targeted for K48-linked ubiquitination and subse-
quent degradation by the HECT E3 ligase WW domain-containing
protein 2 (WWP2) (Yang et al., 2013b). Wwp2-deﬁcient bone
marrow-derived macrophages exhibited increased levels of IFN-
β, TNFα, and IL-6 in response to the TLR3 agonist poly(I:C).
Consistent with this, Wwp2-knockout mice showed an enhanced
susceptibility to poly(I:C)-induced death than WT animals.
Regulation of TLR-proximal signaling molecules by K63-linked
ubiquitination
The activities of many signaling molecules downstream of TLRs
(and also other PRRs), such as TRAFs, NEMO, and TBK1, are regulated
through K63-linked ubiquitination (as discussed in detail below).
In addition, several receptor-proximal signaling molecules have
been shown to be modiﬁed with K63-ubiquitin polymers, among
them the well-studied kinase IRAK1 (Fig. 3). IRAK1 and also
IRAK4 are recruited to MyD88 upon activation of various TLRs,
propagating further signal transduction that leads to NF-κB and
MAPK activation. Interestingly, several groups have shown that
K63-linked ubiquitination of IRAK1 is required for downstream
signaling by recruiting TAK1 and NEMO to the TRAF6 complex
(Ordureau et al., 2008; Schauvliege et al., 2007; Conze et al.,
2008; Jiang et al., 2003). There has been some discrepancy as to
which E3 ubiquitin ligase is responsible for IRAK1 ubiquitination.
While several studies indicated that members of the Pellino E3
ligase family induce K63-linked ubiquitination of IRAK1
(Ordureau et al., 2008; Schauvliege et al., 2006), others have
suggested that TRAF6 is involved in IRAK1 ubiquitination (Conze
et al., 2008). Moreover, Pellino 1 has been shown to mediate the
K63-linked ubiquitination of RIP1 upon its recruitment to the
TLR3–TRIF complex (Chang et al., 2009). Ubiquitinated RIP1 then
recruits NEMO and the TAK1 complex, inducing NF-κB activation.
Ubiquitin-mediated regulation of the cGAS-STING pathway
In contrast to the well-characterized cytosolic RNA sensing path-
ways, the mechanisms of how the cell senses virus-derived DNA, or
host DNA from damaged cells, has just begun to be elucidated. A key
component of the intracellular DNA sensing pathway is the adaptor
protein STING (also called MITA, ERIS, or MPYS) (Ishikawa and Barber,
2008; Zhong et al., 2008; Ishikawa et al., 2009). STING is a membrane-
resident protein found on the ER or mitochondrion. STING was shown
to be activated by viral or immunostimulatory DNA, facilitating its
binding to TBK1 and subsequent IRF3-mediated expression of type-I
IFNs and other cytokines. Functional studies in sting-deﬁcient cells
demonstrated that STING plays a crucial role in dsDNA sensing and
antiviral innate immune responses to HSV-1 and Listeria monocyto-
genes (Ishikawa and Barber, 2008). Infection studies in sting-knockout
mice demonstrated that STING is essential for innate immune signal-
ing upon recognition of foreign intracellular dsDNA (Ishikawa et al.,
2009). Moreover, sting knockout or knockdown also abrogated the
IFN-mediated immune response to certain RNA viruses that are sensed
by RIG-I.
Because STING does not directly sense DNA, it had been proposed
that one or multiple hitherto-unknown DNA sensors mediate STING
activation. In recent years, a plethora of putative cytosolic DNA sensors
have been identiﬁed; however, some of these sensors had great cell-
type speciﬁcity or little in vivo (in mouse) signiﬁcance, leaving it
somewhat unclear whether some of these molecules are indeed bona
ﬁde DNA sensors (Takaoka et al., 2007; Zhang et al., 2011;
Unterholzner et al., 2010; Brunette et al., 2012). More recently, a
new cytosolic DNA sensor, cGAS, was identiﬁed, along with the
detailed mechanism of STING activation upon DNA stimulation
(Zhang et al., 2014b; Diner et al., 2013; Sun et al., 2013; Wu et al.,
2013b; Ablasser et al., 2013). These studies showed that after cGAS
binds to foreign DNA in the cytoplasm, it synthesizes cyclic GMP-AMP
(cGAMP) (Diner et al., 2013; Kranzusch et al., 2013; Sauer et al., 2011),
which is then detected by STING. These studies conﬁrmed previous
ﬁndings, which had shown that STING senses cyclic nucleotides
produced during bacterial infection (Burdette et al., 2011). Further-
more, functional studies in cGas knockout mice as well as structural
analyses strengthened that cGAS-STING is a critical sensing pathway of
cytoplasmic DNA (Kranzusch et al., 2013; Li et al., 2013).
STING activation through K63-linked ubiquitination
The signaling activity of STING is tightly controlled by K63-linked
ubiquitination mediated by two TRIM family members, TRIM56 and
TRIM32 (Fig. 4) (Tsuchida et al., 2010; Zhang et al., 2012a). A cDNA
screen analyzing IFN-β promoter activation after treatment with
various stimuli identiﬁed TRIM56 as a regulatory molecule in the
IFN induction pathway (Tsuchida et al., 2010). TRIM56 promoted type-
I IFN induction in response to poly(dA:dT) and also poly(I:C), con-
sistent with STING's role in both cytoplasmic DNA and RNA detection.
However, TRIM56 did not directly bind to poly(dA:dT), ruling out that
TRIM56 acts as a dsDNA sensor to induce STING-dependent signaling.
Biochemical analysis showed that TRIM56 binds to the C-terminal
domain of STING, and that it induced K63-linked polyubiquitination of
STING. Residue K150 in STING was shown to be critical for K63-linked
ubiquitination by TRIM56; a K150R mutant of STING was no longer
ubiquitinated and was unable to induce IFN-β. Mechanistically, the
K63-linked ubiquitination facilitated dimerization of STING and its
interaction with TBK1, two critical steps in STING-mediated signaling.
A second E3 ligase mediating STING ubiquitination, TRIM32,
was identiﬁed through a cDNA screen testing the effects of 352
Fig. 4. Regulation of the cGAS-STING pathway by ubiquitination. cGAS recognizes
viral DNA in the cytoplasm and synthesizes cyclic GMP-AMP (cGAMP). cGAMP then
activates STING on the ER, inducing downstream signaling for type-I IFN induction.
STING is regulated by three types of polyubiquitination: K11-linked and K63-linked
ubiquitination of K150 by RNF26 and TRIM56 or TRIM32, respectively, facilitating
STING activation and type-I IFN gene expression. Besides K150, TRIM32 ubiquiti-
nates three other residues in STING (K20, K224 and K236). Furthermore, K150 in
STING is covalently modiﬁed by K48-linked ubiquitination mediated by RNF5.
RNF5-induced STING ubiquitination leads to STING degradation.
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ubiquitin-related enzymes on STING ubiquitination (Zhang et al.,
2012a). TRIM32 induced robust K63-linked ubiquitination of
STING, but not of RIG-I, MDA5, and MAVS. Functional studies
revealed that TRIM32 is involved both in cytoplasmic poly(I:C)-
and poly(dA:dT)-induced IFN responses, but not in TLR3 signal
transduction. Biochemical studies showed that the C-terminal NHL
(named for NCL-1, HT2A and Lin-41 repeat) domain of TRIM32
interacted with the transmembrane domain of STING, leading to
K63-linked ubiquitination of STING. This study identiﬁed four
lysine residues implicated in TRIM32-mediated STING ubiquitina-
tion. Whereas individual mutation of K20R, K150R, K224R, or
K236R only partially reduced STING ubiquitination by TRIM32, a
mutant of STING in which all four residues were mutated had a
total loss of ubiquitination and signaling activity. TRIM32-induced
ubiquitination of STING seemed to aid STING binding to TBK1, as
depletion of TRIM32 led to a decrease of endogenous TBK1–STING
interaction upon infection with SeV or HSV-1 (Zhang et al., 2012a).
Regulation of STING stability through K11- and K48-linked
ubiquitination
In addition to its positive regulation by TRIM56 and TRIM32, STING
undergoes K48-linked ubiquitination, leading to its degradation by the
proteasome (Fig. 4). Zhong et al. conducted a yeast two-hybrid screen
using full-length STING as bait, resulting in the identiﬁcation of the E3
ubiquitin ligase RNF5 as a STING interacting molecule (Zhong et al.,
2009). This interaction was mediated by the respective transmem-
brane domains of STING and RNF5. Overexpression of WT RNF5, but
not its catalytically-inactive RING mutant, promoted K48-linked ubi-
quitination and degradation of STING. Furthermore, the authors
identiﬁed K150 in STING as the key residue for K48-linked ubiquitina-
tion, and suggested that STING ubiquitination and degradation by
RNF5 resulted in a negative-regulatory feedback loop to avoid exces-
sive immune signaling in response to viral infection (Zhong et al.,
2009). Cell fractionation and confocal microscopy experiments showed
that RNF5, similar to STING, is localized both at the ER and mitochon-
dria; however, RNF5 targeted speciﬁcally mitochondrion-localized
STING for ubiquitination and subsequent degradation upon viral
infection.
Recently, it has been shown that STING also serves as substrate
for K11-linked polyubiquitination catalyzed by RNF26 (Qin et al.,
2014). Interestingly, this modiﬁcation was shown to be conjugated
to K150 in STING also. To date, the precise fate of K11-linked
ubiquitinated proteins has not been fully elucidated; however,
RNF26-induced ubiquitination prevented STING degradation by
displacing RNF5-mediated K48-linked ubiquitination at K150. In
contrast, RNF26 did not affect the K63-linked polyubiquitination of
STING at K150. Of note, the authors also observed a negative
regulatory role of RNF26 on innate immune signaling speciﬁcally
at later time points during infection, which was due to autophagic
degradation of IRF3 by RNF26. This suggests a model in which
RNF26 has a dual role in regulating innate immune signaling. Early
during infection RNF26 promotes antiviral signaling by protecting
STING from degradation, while at the late phase of viral infection
RNF26 may act as a negative feedback regulator by inducing IRF3
degradation (Qin et al., 2014).
Ubiquitin-dependent regulation of common downstream
signaling molecules of PRRs
RLRs, TLRs and cGAS signal through distinct adaptor proteins,
namely MAVS, MyD88/TRIF and STING, respectively. However,
downstream of these adaptors, the PRR signaling pathways con-
verge on common signaling molecules, leading to the activation of
the aforementioned transcription factors, NF-κB, IRF3/7 and AP-1
(Fig. 5). Among these common downstream signaling molecules
are members of the TRAF protein family of ubiquitin E3 ligases –
especially TRAF3 and 6 – as well as the kinases TBK1 (or IKKε) and
IKKα/β/γ which trigger the activation of the IRF3/7- and NF-κB-
induced signaling arm, respectively (Belgnaoui et al., 2011).
For PRR-mediated NF-κB activation, TRAF6 ﬁrst recruits the TAK1/
TAB1/2 complex. This complex of kinases then phosphorylates NEMO/
IKKγ, activating it to serve as a scaffold for the recruitment of IKKα and
IKKβ. The IKKα/β/γ complex then recruits a signaling complex
consisting of the inhibitor of NF-kappaB-α (IκBα) as well as distinct
NF-κB subunits, such as p65 and p50. IKKβ is then able to induce K48-
linked ubiquitination and degradation of IκBα, which leads to the
release of p65/50, allowing them to translocate into the nucleus to
promote transcription of NF-κB target genes.
For the activation of IRF3/7, the E3 ligase TRAF3 is recruited
either to MAVS or TRIF (Oganesyan et al., 2006; Saha et al., 2006).
TRAF3 also activates NEMO, which in this case forms a distinct
signaling complex with TANK and TBK1 or IKKε. STING also
interacts with TBK1, activating the IRF3-mediated response.
TBK1/IKKε then phosphorylate IRF3/7, leading to their dimeriza-
tion and translocation to the nucleus to induce IRF target genes.
The role of K63-linked ubiquitination in the activation of IKKs and
TBK1
The role of K63-linked ubiquitin polymers in the regulation of
PRR-proximal signaling events and in particular NF-κB activation
has been extensively characterized (reviewed in detail in (Hayden
and Ghosh, 2008; Chen and Chen, 2013; Bhoj and Chen, 2009)).
One of the ﬁrst identiﬁed functions of K63-linked ubiquitination
was described for the signal-transducing activity of TRAF6 (Deng
et al., 2000). Following its recruitment to MyD88 or MAVS, TRAF6,
which belongs to the RING-ﬁnger type E3 ligase family, generates
K63-linked polyubiquitin chains (Fig. 5). These K63-polyubiquitin
chains are essential for the recruitment and activation of the
TAK1/TAB and IKK kinase complexes (Deng et al., 2000; Wang
et al., 2001); however, the target protein of K63-polyubiquitin had
been unknown for quite some time. It has been demonstrated that
TRAF6 catalyzes its own ubiquitination, and also produces unan-
chored K63-linked polyubiquitin (Xia et al., 2009). This ubiquitina-
tion serves a dual role in innate signaling by stabilizing TRAF6
protein levels and by serving as a scaffold for TAB2 binding, which
then recruits and activates TAK1 (Wang et al., 2001; Xia et al.,
2009; Jensen and Whitehead, 2003). The K63-polyubiquitin chains
catalyzed by TRAF6 are also responsible for recruiting NEMO,
which in turn recruits IKKα and IKKβ to the TAK1 complex (Ea
et al., 2006). NEMO has also been shown to bind to diubiquitin
molecules, both K63-linked and mixed linkages (Ivins et al., 2009;
Lo et al., 2009). The ability of NEMO to bind to diubiquitin moieties
is important for its ability to activate the IKK complex, likely
through stabilization of NEMO. To inhibit TRAF6-NEMO signal-
transducing activities, several molecules harboring DUB activity
have been identiﬁed that target speciﬁcally the K63-linked ubi-
quitination of TRAF6, including A20, CYLD and the OTU deubiqui-
tinase 2 (OTUB2) (Boone et al., 2004; Wertz et al., 2004; Wang et
al., 2004; Shembade et al., 2010; Zhang et al., 2006, 2008a; Li et al.,
2010).
For IRF3 activation in response to PRR signaling, TRAF3 is
recruited to MAVS and TRIF after RLR and TLR activation, respec-
tively (Oganesyan et al., 2006; Saha et al., 2006). Similar to TRAF6,
TRAF3 also modiﬁes itself with K63-linked polyubiquitin chains, a
process which is dependent on the E2 enzyme Ubc5 (Paz et al.,
2011; Zeng et al., 2009). This K63-linked ubiquitin chain again
serves as a scaffold for the recruitment of NEMO. NEMO then binds
a complex consisting of TANK and TBK1/IKKε. This interaction
activates TBK1/IKKε to phosphorylate IRF3 and IRF7, inducing the
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transcription of IGSs. The importance of K63-linked ubiquitination
for TRAF3-dependent signaling was strengthened by the identiﬁ-
cation of several DUBs removing the K63-linked ubiquitination
from TRAF3: the deubiquitinating enzyme A (DUBA), OTUB1, as
well as the ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) that
is speciﬁcally subverted by high-risk human papillomaviruses to
downregulate IRF3 activation and PRR responses (Li et al., 2010;
Peng et al., 2014; Kayagaki et al., 2007; Karim et al., 2013).
Furthermore, OTUD7B (OTU domain-containing protein 7B) was
recently shown to interact with TRAF3, removing its K63-linked
ubiquitination, which prevented TRAF3 proteolysis and conse-
quently aberrant non-canonical NF-κB activation (Hu et al., 2013).
TBK1 is another important target of K63-linked ubiquitination,
and at least three E3 ubiquitin ligases have been identiﬁed for
TBK1 ubiquitination. Mind bomb 1 and 2 (MIB 1/2), identiﬁed by a
global proteomic analysis of a human innate immunity interac-
tome, induced K63-polyubiquitin conjugation on residues K69,
K154 and K372 in TBK1. Detailed analysis demonstrated that TBK1
ubiquitination by MIBs was critical for the recruitment of NEMO
and the antiviral response triggered by cytosolic viral RNA (Li et al.,
2011; Wang et al., 2012a). Mechanistically, MIB2 was shown to
bind to the adaptor MAVS involving a highly conserved DLAIS
motif at amino acid positions 438–442 of MAVS; this motif was
critical for MIB2-mediated TBK1 ubiquitination and subsequent
IRF3/7 phosphorylation by TBK1 (Ye et al., 2014). Furthermore,
TRAF3 and Nrdp1 have also been shown to mediate TBK1 K63-
linked ubiquitination (Wang et al., 2009; Parvatiyar et al., 2010).
Recently, structural analysis of the near-full-length TBK1 protein
showed that TBK1 forms a dimer and that K63-linked ubiquitina-
tion (at K30 and K401) of the dimerized TBK1 is required for TBK1
enzymatic activity (Tu et al., 2013).
Inversely, cleavage of K63-linked polyubiquitin from TBK1 by
USP2b or CYLD inhibited the kinase activity of TBK1 (Friedman et
al., 2008; Zhang et al., 2014a). Furthermore, A20 together with the
adaptor protein TAX1BP1 have been shown to disrupt the K63-
linked polyubiquitination of TBK1 (and also of IKKε), an activity
that was not dependent on the DUB activity of A20 but due to the
disruption of the interaction of TBK1/IKKε with TRAF3(Parvatiyar
et al., 2010).
K48-linked ubiquitination to modulate NF-κB- and IRF-mediated
antiviral gene transcription
Degradative K48-linked ubiquitination has been shown to be
essential for NF-κB activation (Fig. 5). In unstimulated cells, NF-κB
subunits, such as the canonical p50 and p65, are kept in an
inactive complex by binding to IκBα. After activation by TAK1/
IKKs, IKKβ phosphorylates IκBα on S32 and S36, leading to the
Fig. 5. Ubiquitin-dependent regulation of common downstream molecules of PRRs. After recognition of viral nucleic acids, RLRs and TLRs signal through their downstream
adaptors MAVS and MyD88/TRIF, respectively. These adaptors then propagate this signal to TRAF6 for NF-κB activation and TRAF3 for IRF3/7 activation. TRAF6 and TRAF3
both induce autoubiquitination, creating a scaffold for downstream signaling partners to interact. K63-linked polyubiquitin on TRAF6 leads to the recruitment of the TAK1/
TAB2/3 complex, which in turn recruits NEMO and the IKK complex to phosphorylate IκBα. Phosphorylation of IκBα then leads to its K48-polyubiquitin-dependent
degradation. Degradation of IκBα releases the NF-κB subunits p50 and p65, allowing for their translocation into the nucleus to activate transcription of target genes. On the
other hand, K63-linked ubiquitination of TRAF3 recruits NEMO speciﬁcally complexed TBK1/IKKε. STING also directly binds to and activates TBK1. TBK1/IKKε then
phosphorylate IRF3 and IRF7, leading to their dimerization and translocation to the nucleus to induce transcription of type-I IFN and antiviral genes. Many proteins in these
signaling cascades are targets for degradative K48-linked ubiquitination and non-degradative types of polyubiquitination. The E3 ligases involved in these ubiquitination
events, as well as the DUBs responsible for removal of polyubiquitin, are indicated. The details of how speciﬁc ubiquitin marks regulate the activities of the illustrated
signaling molecules are described in the text.
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recruitment of the SCFβTrCP E3 ligase (Yaron et al., 1998;
Heissmeyer et al., 2001; Maniatis 1999). Upon recruitment,
SCFβTrCP conjugates K48-linked ubiquitination on IκBα, thereby
targeting it for degradation by the proteasome; this releases the
NF-κB subunits and allows them to translocate into the nucleus to
activate the transcription of target genes.
In addition, many other downstream signaling proteins in the PRR
signaling pathways are regulated through K48-linked ubiquitination
and degradation; in these cases, degradation of the proteins dampens
the NF-κB- and IRF3-mediated immune response. TRAF6 has been
shown to be targeted by TRIM38 for ubiquitination to prevent
excessive NF-κB activation in macrophages (Zhao et al., 2012). Triad3A,
known for its role in the degradation of TLRs, has been reported to
induce K48-linked ubiquitination of speciﬁcally TRAF3 (Nakhaei et al.,
2009), indicating that this E3 ubiquitin ligase targets multiple proteins
in innate immunity to downregulate IRF3-mediated antiviral gene
expression. Another mechanism to avoid excessive NF-κB-mediated
gene transcription is the K48-polyubiquitin-dependent degradation of
NF-κB itself by COMMD1 together with an ubiquitin ligase complex
comprised of Cullin2 (Cul2), Elongins B and C, and SOCS1 (also known
as ECSSOCS1). Activation of p65 involves phosphorylation of S468.
Interestingly, this phosphorylation mark also allows the recruitment
of COMMD1 and Cul2 to chromatin-bound p65, ultimately inducing
p65 degradation to terminate NF-κB transactivation (Geng et al., 2009;
Saccani et al., 2004; Maine et al., 2007; Thoms et al., 2010). A second
nuclear E3 ligase, PDLIM2 (also known as Mystique or SLIM), has been
shown to target p65. PDLIM2 binds to p65 and induces its speciﬁc
relocation to PML-containing intranuclear compartments where p65
undergoes K48-linked ubiquitination and degradation by the 26S
proteasome (Tanaka et al., 2007). USP7 has been reported to counter-
act p65 degradation through removal of K48-linked ubiquitin chains
(Colleran et al., 2013).
Furthermore, TBK1 undergoes K48-linked polyubiquitination,
which is mediated by the E3 ubiquitin ligase DTX4. Speciﬁcally,
DTX4 is recruited to TBK1 by NLRP4 (NACHT, LRR and PYD
domains-containing protein 4), inducing ubiquitination of TBK1
at K670, ultimately leading to TBK1 destabilization (Cui et al.,
2012). The TRAF-interacting protein (TRIP) has also been shown to
negatively regulate the protein stability of TBK1 by binding to and
inducing K48-linked polyubiquitination (Zhang et al., 2012b).
IRF3 is also targeted for K48-polyubiquitin-dependent degradation
(Lin et al., 1998). A negative feedback mechanism for IRF3 activation
was ﬁrst shown for the peptidyl-prolyl isomerase Pin1, which speci-
ﬁcally binds to the phosphorylated active form of IRF3 (Saitoh et al.,
2006). This interaction was observed speciﬁcally upon stimulation of
cells with dsRNA, indicating that Pin1 acts as a feedback negative-
regulatory molecule to dampen the IRF3 response. Further studies
have identiﬁed that the E3 ligases RBCK1 (RBCC protein interacting
with PKC1; better known as HOIL-1) and TRIM21/Ro52 also modify
IRF3 with K48-linked ubiquitin chains, triggering IRF3 degradation and
cessation of target gene expression (Higgs et al., 2008; Zhang et al.,
2008b). The gene expression of both E3 ligases is induced upon viral
infection, suggesting that these two E3 ligases likely also act as
negative feedback regulators of IRF3-dependent transcription. In
addition, IRF7 is also ubiquitinated and degraded by TRIM21 after its
activation (Young et al., 2011). Finally, RAUL, a HECT-domain E3
ubiquitin ligase, was demonstrated to target both IRF3 and IRF7,
comprehensively limiting type-I IFN gene expression (Yu and
Hayward, 2010). Interestingly, KSHV-encoded RTA (replication and
transcription activator), which is the master regulator of KSHV lytic
replication, was shown to recruit RAUL to IRFs, decreasing antiviral
signaling and ultimately allowing for efﬁcient virus replication (Yu and
Hayward, 2010). Moreover, several herpesviruses actively induce K48-
linked ubiquitination and proteolysis of IRF3/7 using their immediate-
early protein ICP0, which exhibits E3 ligase activity (Lin et al., 2004;
Henderson et al., 2005; Saira et al., 2007).
Regulation of NEMO by K27-linked, K29-linked and linear
polyubiquitination
In addition to its K63-polyubiquitin binding properties (as
described above), NEMO has been shown to serve as a substrate
for K27-linked polyubiquitination (Arimoto et al., 2010). The RING
E3 ligase TRIM23 binds to NEMO and conjugates K27-linked
ubiquitin chains to multiple lysine residues (K165, K309, K325,
K326 and K344) in NEMO (Fig. 5, inset). Ubiquitination of NEMO
led to an increase in IFN-β induction, indicating that TRIM23
promotes the signaling activity of NEMO. In support of this, a
catalytically-inactive RING mutant of TRIM23 had a dominant-
negative effect on ISRE-, IFN-β- and NF-κB-dependent gene
transcription. Knockdown studies showed that the signal-tran-
sducing activity of NEMO was limited in trim23-depleted cells,
resulting in an increase in virus growth (Arimoto et al., 2010). The
fate of K27-linked ubiquitinated NEMO and other cellular sub-
strates has not been fully characterized, and in fact, another study
has shown that K27-linked ubiquitination of different lysine
residues in NEMO by a Shigella effector protein possessing E3
ligase activity (IpaH9.8) leads to the proteasomal degradation of
NEMO, a strategy utilized by this bacterium to perturb the host
inﬂammatory response (Ashida et al., 2010). Further studies will
be needed to characterize the effects of K27-linked ubiquitin
conjugation in general and on NEMO speciﬁcally.
NEMO is also modiﬁed by K29-linked ubiquitin chains (Zotti
et al., 2011). Using NEMO as bait in a yeast two-hybrid assay,
TRAF7 was identiﬁed as a NEMO binding partner. Further char-
acterization showed that expression of TRAF7 decreased NF-κB
promoter activation following various stimuli. Using ubiquitin
mutants in which all except one of the 7 internal lysines are
mutated, the authors further showed that TRAF7 catalyzes speci-
ﬁcally K29-linked ubiquitin chains to NEMO as well as to the NF-
κB subunit p65. This ubiquitin mark led to reduced protein levels
of NEMO and p65, which the authors determined to be due to
lysosomal degradation (Zotti et al., 2011). Of note, this ﬁnding is in
accordance with other reports that have suggested that K29-linked
polyubiquitin represents a signal for protein degradation by the
lysosome (Kulathu and Komander, 2012).
NEMO has also been shown to be a target of linear ubiquitin
chains (Tokunaga et al., 2009; Rahighi et al., 2009). Initial reports
showed that NEMO is ubiquitinated by LUBAC at the residues K285
and K309. Conjugated linear polyubiquitin led to the stabilization
of the TAK1/TAB and IKK complexes due to recruitment of TAB2
using its NZF domains (Tokunaga et al., 2009). While linear
ubiquitination activates TAK1 and NF-κB activation, it has also
been reported to dampen the type-I IFN response mediated by
RIG-I and MAVS (Belgnaoui et al., 2012). NEMO modiﬁed with two
or more linear ubiquitin moieties, but not unmodiﬁed NEMO,
interacted with TRAF3, disrupting the MAVS–TRAF3 complex,
which is critical for antiviral IFN induction. This study also showed
that in cells deﬁcient in SHARPIN, which is critical for LUBAC
function, VSV replicated less efﬁciently due to a prolonged and
increased type-I IFN response. In contrast, NF-κB activation was
impaired in SHARPIN-knockout cells (Belgnaoui et al., 2012).
Additional studies have demonstrated that NEMO, using its UBAN
(ubiquitin binding in ABIN and NEMO) motif, binds to linear
ubiquitin chains, which is independent of its direct ubiquitin
conjugation. The crystal structure of the UBAN motif of NEMO
bound to linear diubiquitin provided detailed evidence for the
speciﬁcity of linear ubiquitin binding versus interaction with K63-
or K48-linked ubiquitin chains. The speciﬁc residues which were
involved in linear ubiquitin binding were essential for NF-κB
activation, indicating that ubiquitin binding also leads to stabiliza-
tion of NEMO and its activation (Rahighi et al., 2009). Together,
these studies indicate that NEMO-dependent signaling is
M.E. Davis, M.U. Gack / Virology 479-480 (2015) 52–6562
delicately regulated by at least four different linkage types of
polyubiquitin. More detailed studies, however, will be required to
fully understand the dynamic interplay of these ubiquitin-
dependent regulatory mechanisms for modulating NEMO-
mediated antiviral and proinﬂammatory host responses.
Concluding Remarks
Given the pivotal role of ubiquitination in modulating innate
sensing pathways, we eagerly await the identiﬁcation of disease-
relevant mutations in the key enzymes of the ubiquitin conjuga-
tion system. Furthermore, while much study has been done
looking at the linear, K63- and K48- linked ubiquitination of
proteins in PRR signaling cascades, future studies should be
focused on dissecting the role of other atypical polyubiquitin
chains as well as branched ubiquitin chains in innate immunity.
Moreover, it remains to be elucidated how various ubiquitin
modiﬁcations work together (or against each other) to dynami-
cally modulate the signal-transducing activity of individual pro-
teins, and the pathways as a whole. It also remains to be seen how
different E3 ligases and DUBs, which often differ in their expres-
sion patterns, ubiquitin-linkage speciﬁcities, and interaction
modes, regulate one particular signaling protein (such as STING
or NEMO) to induce an effective antiviral response. Detailed
insights into the ubiquitin-dependent regulatory networks in
PRR-mediated innate immunity will allow us to exploit this
knowledge for the development of new clinical therapies, both
for infectious diseases as well as disorders caused by a hyperactive
inﬂammatory response.
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